Angiotensin receptor I stimulates osteoprogenitor proliferation through TGFβ-mediated signaling

Journal of Cellular Physiology

Volumn 230, Issue 7, 2015, Pages 1466-1474

  Querques, Francesca ^a,b   Cantilena, Bruno ^a,c   Cozzolino, Carmine ^a,b   Esposito, Maria Teresa ^a,c   Passaro, Fabiana ^a,b   Parisi, Silvia ^a,b,c   Lombardo, Barbara ^a,b   Russo, Tommaso ^a,b   Pastore, Lucio ^a,b  

^a CEINGE BIOTECNOLOGIE AVANZATE   (Italy)

^b UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^c European School of Molecular Medicine SEMM   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; LOSARTAN POTASSIUM; SMAD2 PROTEIN; SMAD3 PROTEIN; TRANSFORMING GROWTH FACTOR BETA; 1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN DERIVATIVE; IMIDAZOLE DERIVATIVE; LOSARTAN; PYRIDINE DERIVATIVE; SMALL INTERFERING RNA;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MASS; BONE METABOLISM; CELL CULTURE; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CELL STIMULATION; EMBRYO; EMBRYONIC STEM CELL; GENE EXPRESSION; GENE SILENCING; GENETIC SCREENING; MESENCHYMAL STEM CELL; MESENCHYME CELL; MOUSE; NONHUMAN; OSSIFICATION; OSTEOBLAST; OSTEOPROGENITOR CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; SIGNAL TRANSDUCTION; ANIMAL; CYTOLOGY; GENE EXPRESSION REGULATION; GENETICS; HUMAN; MESENCHYMAL STROMA CELL; METABOLISM; PHYSIOLOGY;

RODENTIA;

ANGIOTENSIN II TYPE 2 RECEPTOR BLOCKERS; ANGIOTENSINS; ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMANS; IMIDAZOLES; LOSARTAN; MESENCHYMAL STROMAL CELLS; MICE; OSTEOBLASTS; PYRIDINES; RECEPTOR, ANGIOTENSIN, TYPE 1; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; TRANSFORMING GROWTH FACTOR BETA;

EID: 84925607496     PISSN: 00219541     EISSN: 10974652     Source Type: Journal    
DOI: 10.1002/jcp.24887     Document Type: Article

References (39)

1. Asaba Y, Ito M, Fumoto T, Watanabe K, Fukuhara R, Takeshita S, Nimura Y, Ishida J, Fukamizu A, Ikeda K. 2009. Activation of renin-angiotensin system induces osteoporosis independently of hypertension. J Bone Miner Res 24:241-250.
2. Brooke BS, Habashi JP, Judge DP, Patel N, Loeys B, Dietz HC, 3rd. 2008. Angiotensin II blockade and aortic-root dilation in Marfan's syndrome. N Engl J Med 358:2787-2795.
3. Broulik PD, Tesar V, Zima T, Jirsa M. 2001. Impact of antihypertensive therapy on the skeleton: effects of enalapril and AT1 receptor antagonist losartan in female rats. Physiol Res 50:353-358.
4. Bruder SP, Jaiswal N, Haynesworth SE. 1997. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. J Cell Biochem 64:278-294.
5. Cohn RD, van Erp C, Habashi JP, Soleimani AA, Klein EC, Lisi MT, Gamradt M, ap Rhys CM, Holm TM, Loeys BL, Ramirez F, Judge DP, Ward CW, Dietz HC. 2007. Angiotensin II type 1 receptor blockade attenuates TGF-beta-induced failure of muscle regeneration in multiple myopathic states. Nat Med 13:204-210.
6. Daniels D, Yee DK, Fluharty SJ. 2007. Angiotensin II receptor signalling. Exp Physiol 92:523-527.
7. Dennis MS, Lo KM, McDowall M, West T. 2002. Fractures after stroke: Frequency, types, and associations. Stroke 33:728-734.
8. Digirolamo CM, Stokes D, Colter D, Phinney DG, Class R, Prockop DJ. 1999. Propagation and senescence of human marrow stromal cells in culture: A simple colony-forming assay identifies samples with the greatest potential to propagate and differentiate. Br J Haematol 107:275-281.
9. Erlebacher A, Derynck R. 1996. Increased expression of TGF-beta 2 in osteoblasts results in an osteoporosis-like phenotype. J Cell Biol 132:195-210.
10. Esposito MT, Di Noto R, Mirabelli P, Gorrese M, Parisi S, Montanaro D, Del Vecchio L, Pastore L. 2009. Culture conditions allow selection of different mesenchymal progenitors from adult mouse bone marrow. Tissue Eng Part A 15:2525-2536.
11. Gu SS, Zhang Y, Li XL, Wu SY, Diao TY, Hai R, Deng HW. 2012. Involvement of the skeletal renin-angiotensin system in age-related osteoporosis of ageing mice. Biosci Biotechnol Biochem 76:1367-1371.
12. Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. 2006. Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome. Science 312:117-121.
13. Hagiwara H, Hiruma Y, Inoue A, Yamaguchi A, Hirose S. 1998. Deceleration by angiotensin II of the differentiation and bone formation of rat calvarial osteoblastic cells. J Endocrinol 156:543-550.
14. Hiruma Y, Inoue A, Hirose S, Hagiwara H. 1997. Angiotensin II stimulates the proliferation of osteoblast-rich populations of cells from rat calvariae. Biochem Biophys Res Commun 230:176-178.
15. Izu Y, M;1;izoguchi F, Kawamata A, Hayata T, Nakamoto T, Nakashima K, Inagami T, Ezura Y, Noda M. 2009. Angiotensin II type 2 receptor blockade increases bone mass. J Biol Chem 284:4857-4864.
16. Kanis J, Oden A, Johnell O. 2001. Acute and long-term increase in fracture risk after hospitalization for stroke. Stroke 32:702-706.
17. Karsenty G. 2006. Convergence between bone and energy homeostases: Leptin regulation of bone mass. Cell Metab 4:341-348.
18. Kawaguchi Y, Takagi K, Hara M, Fukasawa C, Sugiura T, Nishimagi E, Harigai M, Kamatani N. 2004. Angiotensin II in the lesional skin of systemic sclerosis patients contributes to tissue fibrosis via angiotensin II type 1 receptors. Arthritis Rheum 50:216-226.
19. Kitahara K, Ishijima M, Rittling SR, Tsuji K, Kurosawa H, Nifuji A, Denhardt DT, Noda M. 2003. Osteopontin deficiency induces parathyroid hormone enhancement of cortical bone formation. Endocrinology 144:2132-2140.
20. Li G, Wang M, Hao L, Loo WT, Jin L, Cheung MN, Chow LW, Ng EL. 2014. Angiotensin II induces mitochondrial dysfunction and promotes apoptosis via JNK signalling pathway in primary mouse calvaria osteoblast. Arch Oral Biol 59:513-523.
21. Li XC, Zhuo JL. 2008. Intracellular ANG II directly induces in vitro transcription of TGF-beta1, MCP-1, and NHE-3 mRNAs in isolated rat renal cortical nuclei via activation of nuclear AT1a receptors. Am J Physiol Cell Physiol 294:C1034-C1045.
22. Lucarini L, Sticchi E, Sofi F, Pratesi G, Pratesi C, Pulli R, Gensini GF, Abbate R, Pepe G, Fatini C. 2009. ACE and TGFBR1 genes interact in influencing the susceptibility to abdominal aortic aneurysm. Atherosclerosis 202:205-210.
23. Lynn H, Kwok T, Wong SY, Woo J, Leung PC. 2006. Angiotensin converting enzyme inhibitor use is associated with higher bone mineral density in elderly Chinese. Bone 38:584-588.
24. Mariotti E, Mirabelli P, Abate G, Schiattarella M, Martinelli P, Fortunato G, Di Noto R, Del Vecchio L. 2008. Comparative characteristics of mesenchymal stem cells from human bone marrow and placenta: CD10, CD49d, and CD56 make a difference. Stem Cells Dev 17:1039-1041.
25. Nakai K, Kawato T, Morita T, Iinuma T, Kamio N, Zhao N, Maeno M. 2013. Angiotensin II induces the production of MMP-3 and MMP-13 through the mapk signaling pathways via the AT(1) receptor in osteoblasts. Biochimie 95:922-933.
26. NIH Consensus Development Panel on Osteoporosis Prevention DaT. 2001. Osteoporosis prevention, diagnosis, and therapy. JAMA 285:785-795.
27. Nistala H, Lee-Arteaga S, Carta L, Cook JR, Smaldone S, Siciliano G, Rifkin AN, Dietz HC, Rifkin DB, Ramirez F. 2010b. Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome. Hum Mol Genet 19:4790-4798.
28. Nistala H, Lee-Arteaga S, Siciliano G, Smaldone S, Ramirez F. 2010a. Extracellular regulation of transforming growth factor beta and bone morphogenetic protein signaling in bone. Ann N Y Acad Sci 1192:253-256.
29. Ono N, Nakashima K, Schipani E, Hayata T, Ezura Y, Soma K, Kronenberg HM, Noda M. 2007. Constitutively active parathyroid hormone receptor signaling in cells in osteoblastic lineage suppresses mechanical unloading-induced bone resorption. J Biol Chem 282:25509-25516.
30. Parisi S, Passaro F, Aloia L, Manabe I, Nagai R, Pastore L, Russo T. 2008. Klf5 is involved in self-renewal of mouse embryonic stem cells. J Cell Sci 121:2629-2634.
31. Ramirez F, Dietz HC. 2007a. Fibrillin-rich microfibrils: Structural determinants of morphogenetic and homeostatic events. J Cell Physiol 213:326-330.
32. Ramirez F, Dietz HC. 2007b. Marfan syndrome: From molecular pathogenesis to clinical treatment. Curr Opin Genet Dev 17:252-258.
33. Roelen BA, Dijke P. 2003. Controlling mesenchymal stem cell differentiation by TGFBeta family members. J Orthop Sci 8:740-748.
34. Shimizu H, Nakagami H, Osako MK, Hanayama R, Kunugiza Y, Kizawa T, Tomita T, Yoshikawa H, Ogihara T, Morishita R. 2008. Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J 22:2465-2475.
35. Shimizu H, Nakagami H, Osako MK, Nakagami F, Kunugiza Y, Tomita T, Yoshikawa H, Rakugi H, Ogihara T, Morishita R. 2009. Prevention of osteoporosis by angiotensin-converting enzyme inhibitor in spontaneous hypertensive rats. Hypertens Res 32:786-790.
36. Urano T, Yashiroda H, Muraoka M, Tanaka K, Hosoi T, Inoue S, Ouchi Y, Toyoshima H. 1999. P57(Kip2) is degraded through the proteasome in osteoblasts stimulated to proliferation by transforming growth factor beta1. J Biol Chem 274:12197-12200.
37. von der Recke P, Hansen MA, Hassager C. 1999. The association between low bone mass at the menopause and cardiovascular mortality. Am J Med 106:273-278.
38. Zhao X, Wang JX, Feng YF, Wu ZX, Zhang Y, Shi L, Tan QC, Yan YB, Lei W. 2014. Systemic treatment with telmisartan improves femur fracture healing in mice. PLoS ONE 9:e92085.
39. Zhang Y, Shao L, Ma A, Guan G, Wang J, Wang Y, Tian G. 2014. Telmisartan delays myocardial fibrosis in rats with hypertensive left ventricular hypertrophy by TGF-β1/Smad signal pathway. Hypertens Res 37:43-49.